Patricia M. Danzon

Names

Identifer

Contact

Affiliations

• University of Pennsylvania / Wharton School of Business
  • EDIRC entry
  • location:

Research profile

author of:

• The Political Economy of Workers' Compensation: Lessons for Product Liability (RePEc:aea:aecrev:v:78:y:1988:i:2:p:305-10)
  by Danzon, Patricia M
• The Effects of Malpractice Litigation on Physicians' Fees and Incomes (RePEc:aea:aecrev:v:80:y:1990:i:2:p:122-27)
  by Danzon, Patricia M & Pauly, Mark V & Kington, Raynard S
• Liability for Medical Malpractice (RePEc:aea:jecper:v:5:y:1991:i:3:p:51-69)
  by Patricia M. Danzon
• Health Care Reform (RePEc:bla:ausecr:v:27:y:1994:i:2:p:81-88)
  by Patricia M. Danzon & Grant D. H. Maclaine
• Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand (RePEc:bpj:fhecpo:v:7:y:2004:n:2)
  by Danzon Patricia M. & Ketcham Jonathan D.
• Liability for medical malpractice (RePEc:eee:heachp:1-26)
  by Danzon, Patricia M.
• The Swedish patient compensation system: Myths and realities (RePEc:eee:irlaec:v:14:y:1994:i:4:p:453-466)
  by Danzon, Patrigia M.
• "Crises" in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market (RePEc:eee:jbfina:v:32:y:2008:i:1:p:157-169)
  by Harrington, Scott E. & Danzon, Patricia M. & Epstein, Andrew J.
• Price, Financial Quality, and Capital Flows in Insurance Markets (RePEc:eee:jfinin:v:6:y:1997:i:1:p:3-38)
  by Cummins, J. David & Danzon, Patricia M.
• Hospital `profits' : The effects of reimbursement policies (RePEc:eee:jhecon:v:1:y:1982:i:1:p:29-52)
  by Danzon, Patricia Munch
• Cross-national price differences for pharmaceuticals: how large, and why? (RePEc:eee:jhecon:v:19:y:2000:i:2:p:159-195)
  by Danzon, Patricia M. & Chao, Li-Wei
• Welfare effects of supplementary insurance: a comment (RePEc:eee:jhecon:v:21:y:2002:i:5:p:923-926)
  by Danzon, Patricia M.
• Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances (RePEc:eee:jhecon:v:24:y:2005:i:2:p:317-339)
  by Danzon, Patricia M. & Nicholson, Sean & Pereira, Nuno Sousa
• Liability and liability insurance for medical malpractice (RePEc:eee:jhecon:v:4:y:1985:i:4:p:309-331)
  by Danzon, Patricia M.
• Separation of the redistributive and allocative functions of government : A public choice perspective (RePEc:eee:pubeco:v:24:y:1984:i:3:p:373-380)
  by Flowers, Marilyn R. & Danzon, Patricia M.
• Regulation of the Biopharmaceutical Industry (RePEc:elg:eechap:12771_14)
  by Patricia M. Danzon
• Effects of Regulation on Drug Launch and Pricing in Interdependent Markets (RePEc:eme:aheszz:s0731-2199(2012)0000023005)
  by Patricia M. Danzon & Andrew J. Epstein
• Unknown item RePEc:fth:chices:59 (paper)
• Unknown item RePEc:fth:chices:60 (paper)
• Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy (RePEc:max:cprpbr:23)
  by Patricia M. Danzon & Stephen B. Soumerai
• Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy (RePEc:max:cprrpt:23)
  by Patricia M. Danzon & Stephen B. Soumerai
• At what price? (RePEc:nat:nature:v:449:y:2007:i:7159:d:10.1038_449176a)
  by Patricia M. Danzon
• Regulation of the Pharmaceutical-Biotechnology Industry (RePEc:nbr:nberch:12572)
  by Patricia M. Danzon & Eric L. Keuffel
• The Effects of Price Regulation on Productivity in Pharmaceuticals (RePEc:nbr:nberch:8397)
  by Patricia M. Danzon & Allison Percy
• Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand (RePEc:nbr:nberch:9868)
  by Patricia M. Danzon & Jonathan D. Ketcham
• Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand (RePEc:nbr:nberwo:10007)
  by Patricia M. Danzon & Jonathan D. Ketcham
• Mergers and Acquisitions in the Pharmaceutical and Biotech Industries (RePEc:nbr:nberwo:10536)
  by Patricia M. Danzon & Andrew Epstein & Sean Nicholson
• Effects of Regulation on Drug Launch and Pricing in Interdependent Markets (RePEc:nbr:nberwo:14041)
  by Patricia M. Danzon & Andrew J. Epstein
• Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement (RePEc:nbr:nberwo:17174)
  by Patricia M. Danzon & Andrew W. Mulcahy & Adrian K. Towse
• Vaccine Supply: Effects Of Regulation And Competition (RePEc:nbr:nberwo:17205)
  by Patricia M. Danzon & Nuno S. Pereira
• Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets (RePEc:nbr:nberwo:17226)
  by Patricia M. Danzon & Michael F. Furukawa
• Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context (RePEc:nbr:nberwo:18593)
  by Patricia M. Danzon & Adrian K. Towse & Jorge Mestre-Ferrandiz
• Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality (RePEc:nbr:nberwo:9007)
  by Sean Nicholson & Patricia M. Danzon & Jeffrey S. McCullough
• Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances (RePEc:nbr:nberwo:9615)
  by Patricia M. Danzon & Sean Nicholson & Nuno Sousa Pereira
• The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s (RePEc:nbr:nberwo:9874)
  by Patricia M. Danzon & Y. Richard Wang & Liang Wang
• Trade and Price Differentials for Pharmaceuticals: Policy Options (RePEc:ohe:monogr:000430)
  by Patricia Danzon
• Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison (RePEc:ohe:monogr:000462)
  by Patricia Danzon;Li-Wei Chao
• The Life Cycle of Pharmaceuticals: A Cross-National Perspective (RePEc:ohe:monogr:000480)
  by Patricia Danzon;Jeong Kim
• Pharmaceutical Pricing in Europe: Is Differential Pricing a Win-Win Solution? (RePEc:ohe:occpap:000191)
  by Patricia Danzon;Martina Garau;Adrian Towse
• Tort Reform: The Case of Medical Malpractice (RePEc:oup:oxford:v:10:y:1994:i:1:p:84-98)
  by Danzon, Patricia M
• The Oxford Handbook of the Economics of the Biopharmaceutical Industry (RePEc:oxp:obooks:9780199742998)
  by None
• Alternative Liability Regimes for Medical Injuries (RePEc:pal:gpprii:v:15:y:1990:i:1:p:3-21)
  by Patricia M Danzon
• Contingent Fees for Personal Injury Litigation (RePEc:rje:bellje:v:14:y:1983:i:spring:p:213-224)
  by Patricia Munch Danzon
• Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues (RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4)
  by Patricia M. Danzon
• Vaccine Supply: Effects of Regulation and Competition (RePEc:taf:ijecbs:v:18:y:2011:i:2:p:239-271)
  by Patricia Danzon & Nuno Sousa Pereira
• Pharmacy Benefit Management: Are Reporting Requirements Pro- or Anticompetitive? (RePEc:taf:ijecbs:v:22:y:2015:i:2:p:245-261)
  by Patricia M. Danzon
• Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU (RePEc:taf:ijecbs:v:4:y:1997:i:3:p:301-322)
  by Patricia Danzon
• The Economic Implications of Public Disability Insurance in the United States (RePEc:ucp:jlabec:v:11:y:1993:i:1:p:s170-200)
  by Danzon, Patricia M
• Health Insurance and the Growth in Pharmaceutical Expenditures (RePEc:ucp:jlawec:doi:10.1086/368005)
  by Patricia M. Danzon & Mark V. Pauly
• The Frequency and Severity of Medical Malpractice Claims (RePEc:ucp:jlawec:v:27:y:1984:i:1:p:115-48)
  by Danzon, Patricia
• Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment (RePEc:ucp:jlawec:v:36:y:1993:i:1:p:587-94)
  by Danzon, Patricia
• Does Regulation Drive out Competition in Pharmaceutical Markets? (RePEc:ucp:jlawec:v:43:y:2000:i:2:p:311-57)
  by Danzon, Patricia M & Chao, Li-Wei
• Worker's Compensation Rate Regulation: How Price Controls Increase Costs (RePEc:ucp:jlawec:v:44:y:2001:i:1:p:1-36)
  by Danzon, Patricia M & Harrington, Scott E
• Tort Liability: A Minefield for Managed Care? (RePEc:ucp:jlstud:v:26:y:1997:i:2:p:491-519)
  by Danzon, Patricia M
• Comments on "The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions." (RePEc:ucp:jlstud:v:30:y:2001:i:2:p:661-68)
  by Danzon, Patricia & Sloan, Frank
• Price Cutting in Liability Insurance Markets (RePEc:ucp:jnlbus:v:67:y:1994:i:4:p:511-38)
  by Harrington, Scott E & Danzon, Patricia M
• Rate Regulation, Safety Incentives, and Loss Growth in Workers' Compensation Insurance (RePEc:ucp:jnlbus:v:73:y:2000:i:4:p:569-95)
  by Harrington, Scott E & Danzon, Patricia M
• A general model of the impact of absenteeism on employers and employees (RePEc:wly:hlthec:v:11:y:2002:i:3:p:221-231)
  by Mark V. Pauly & Sean Nicholson & Judy Xu & Dan Polsky & Patricia M. Danzon & James F. Murray & Marc L. Berger
• The impact of price regulation on the launch delay of new drugs—evidence from twenty‐five major markets in the 1990s (RePEc:wly:hlthec:v:14:y:2005:i:3:p:269-292)
  by Patricia M. Danzon & Y. Richard Wang & Liang Wang
• Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition, and Procurement (RePEc:wly:hlthec:v:24:y:2015:i:2:p:238-252)
  by Patricia M. Danzon & Andrew W. Mulcahy & Adrian K. Towse
• Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context (RePEc:wly:hlthec:v:24:y:2015:i:3:p:294-301)
  by Patricia Danzon & Adrian Towse & Jorge Mestre‐Ferrandiz
• Medical negligence and the NHS: an economic analysis (RePEc:wly:hlthec:v:8:y:1999:i:2:p:93-101)
  by Adrian Towse & Patricia Danzon
• A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth (RePEc:wly:jpamgt:v:14:y:1995:i:4:p:636-638)
  by Patricia M. Danzon
• Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00 (RePEc:wly:jpamgt:v:2:y:1982:i:1:p:141-141)
  by Patricia Munch Danzon
• Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95 (RePEc:wly:jpamgt:v:3:y:1983:i:1:p:154-154)
  by Patricia Munch Danzon
• Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50 (RePEc:wly:jpamgt:v:3:y:1983:i:1:p:154-155)
  by Patricia Munch Danzon
• Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion (RePEc:wly:mgtdec:v:28:y:2007:i:4-5:p:231-250)
  by Ernst R. Berndt & Patricia M. Danzon & Gregory B. Kruse
• Mergers and acquisitions in the pharmaceutical and biotech industries (RePEc:wly:mgtdec:v:28:y:2007:i:4-5:p:307-328)
  by Patricia M. Danzon & Andrew Epstein & Sean Nicholson
• The Effects of Malpractice Litigation on Physicians' Fees and Incomes (RePEc:zbw:cbscwp:59)
  by Danzon, Patricia M. & Pauly, Mark V. & Kington, Raynard S.
• Mandated Employment-Based Health Insurance: Incidence and Efficiency Effects (RePEc:zbw:cbscwp:60)
  by Danzon, Patricia M.